Antimicrobial compounds

Antimicrobial compounds are a broad category of chemical agents, including antibiotics, antivirals, antifungals, and antiparasitics, designed to kill or inhibit the growth of microorganisms (World Health Organization, 2023). Rather than representing a single molecular target, this term encompasses a wide range of drugs that act on various essential microbial processes, such as cell wall synthesis, protein translation, and nucleic acid replication (National Center for Biotechnology Information, 2021). These compounds are fundamental in treating infectious diseases and preventing complications in medical procedures like surgery and chemotherapy (StatPearls, 2023). However, the term is considered a therapeutic class rather than a specific biological target like a receptor or enzyme. A major challenge associated with these compounds is the global rise of antimicrobial resistance (AMR), where pathogens evolve mechanisms to evade the effects of these drugs, rendering standard treatments ineffective (CDC, 2022). In the context of drug development, researchers focus on specific microbial proteins or pathways as the actual targets for these compounds. Consequently, this term is used to describe a broad therapeutic strategy rather than a single point of pharmacological intervention.

Other names

AntimicrobialsAnti-infective agentsAntibioticsAntifungalsAntiviralsAntiparasitics

Antimicrobial compounds exert their effects through several distinct mechanisms: inhibition of cell wall synthesis (e.g., beta-lactams), inhibition of protein synthesis (e.g., aminoglycosides, tetracyclines), inhibition of nucleic acid synthesis (e.g., fluoroquinolones, rifamycins), and disruption of metabolic pathways (e.g., sulfonamides) (National Center for Biotechnology Information, 2021).